Cite
A Possible Early Biomarker for Bicuspid Aortopathy: Circulating Transforming Growth Factor β-1 to Soluble Endoglin Ratio
MLA
Gilda Cobellis, et al. “A Possible Early Biomarker for Bicuspid Aortopathy: Circulating Transforming Growth Factor β-1 to Soluble Endoglin Ratio.” Circulation Research, vol. 120, no. 11, Apr. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4cf4478f163b69d592be73ced382969b&authtype=sso&custid=ns315887.
APA
Gilda Cobellis, Marisa De Feo, Giuseppe Santarpino, Marianna Buonocore, Theodor Fischlein, Ciro Bancone, Amalia Forte, Alessandro Della Corte, & Marilena Cipollaro. (2017). A Possible Early Biomarker for Bicuspid Aortopathy: Circulating Transforming Growth Factor β-1 to Soluble Endoglin Ratio. Circulation Research, 120(11).
Chicago
Gilda Cobellis, Marisa De Feo, Giuseppe Santarpino, Marianna Buonocore, Theodor Fischlein, Ciro Bancone, Amalia Forte, Alessandro Della Corte, and Marilena Cipollaro. 2017. “A Possible Early Biomarker for Bicuspid Aortopathy: Circulating Transforming Growth Factor β-1 to Soluble Endoglin Ratio.” Circulation Research 120 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4cf4478f163b69d592be73ced382969b&authtype=sso&custid=ns315887.